Generic name: pimavanserin tartrate 17mg
Dosage form: tablet, coated
Medically reviewed on March 8, 2018.
General Dosing Information
The recommended dose of NUPLAZID is 34 mg, taken orally as two 17 mg strength tablets once daily, without titration.
NUPLAZID can be taken with or without food.
Dosage Modifications for Concomitant Use with CYP3A4 Inhibitors and Inducers
- Coadministration with Strong CYP3A4 Inhibitors
The recommended dose of NUPLAZID when coadministered with strong CYP3A4 inhibitors (e.g., ketoconazole) is 17 mg, taken orally as one tablet once daily [see Drug Interactions (7.1)].
- Coadministration with Strong CYP3A4 Inducers
Monitor patients for reduced efficacy if NUPLAZID is used concomitantly with strong CYP3A4 inducers; an increase in NUPLAZID dosage may be needed [see Drug Interactions (7.1)].
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Nuplazid (pimavanserin)
- Nuplazid Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews
- Drug class: atypical antipsychotics